Vitura HealthASX:VIT OCF Yield % is 8.26 as of Jul. 06, 2026, which is 37% above its 10-year median of 6.01. The stock has 8 warning signs investors should review. Among 1,007 Drug Manufacturers companies, Vitura Health ranks better than 74.28% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Vitura Health OCF Yield % Related Terms
Vitura Health OCF Yield % Historical Data
* Premium members only.
The historical data trend for Vitura Health's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Vitura Health's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vitura Health OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vitura Health's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Vitura Health's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vitura Health (ASX:VIT) has a OCF Yield % of 8.26 as of Jul. 06, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Vitura Health and its competitors. This is 37% above median its historical median of 6.01. According to the industry distribution chart, Vitura Health ranks #259 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 25.7%.
Is Vitura Health's OCF Yield % too high?
Vitura Health's current OCF Yield % of 8.26 is 37% above median its 10-year median of 6.01. The Drug Manufacturers industry median OCF Yield % is 3.41. Vitura Health's value of 8.26 is 142.2% above this industry median. Based on the distribution chart, Vitura Health ranks #259 out of 1007 companies in the Drug Manufacturers industry, which is above the industry midpoint.
How does Vitura Health's OCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Vitura Health ranks #259 out of 1007 companies for OCF Yield %. This puts Vitura Health in the upper half of its industry. The industry median OCF Yield % is 3.41. Vitura Health's value of 8.26 is 142.2% above this benchmark. While the company's 10-year median is 6.01 vs. the industry median of 3.41, Vitura Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.41, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vitura Health's current OCF Yield % of 8.26 is 142.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Vitura Health and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vitura Health's current OCF Yield % is 8.26, which is 37% above median its own 10-year median of 6.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitura Health stock overvalued right now?
Based on GuruFocus' analysis, Vitura Health (ASX:VIT) is currently considered Significantly Undervalued. The stock's GF Value™ is A$0.10, compared to a current price of A$0.03 — trading 73% below its estimated fair value. The current OCF Yield % is 8.26, which is 37% above median its 10-year median of 6.01 and 142.2% above the Drug Manufacturers industry median of 3.41. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Vitura Health (ASX:VIT), the current OCF Yield % is 8.26 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vitura Health Ltd is focused on creating medicinal cannabis products and digital health solutions that connect and strengthen the ecosystem between patients, prescribers, pharmacists, and suppliers. The company has two business segments namely, Sales and distribution (involving the sale and distribution of medical products including medicinal cannabis, psychedelic drugs, and smoking cessation products) and Clinics and services (involving the operation of medicinal cannabis clinics and the provision of related services). The company generates the majority of its revenue from the Sales and distribution segment. Geographically the company generates the majority of its revenue from Australia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:VIT has been successfully added to your 